Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how Cognitive Processing Therapy (CPT), a type of talk therapy, can assist people with PTSD and reduce their risk of heart disease. Researchers aim to determine if CPT can lower inflammation and improve heart-related functions by reducing stress. Participants will either receive the therapy or join a waitlist for it. Individuals who have experienced a traumatic event, exhibit PTSD symptoms, and possess heart disease risk factors like high blood pressure or diabetes may be suitable for this study. As an unphased trial, this study provides a unique opportunity to enhance understanding of how CPT can benefit those with PTSD and heart disease risk factors.
Will I have to stop taking my current medications?
The trial requires that you do not change your psychiatric or cardiovascular medications within 4 weeks before starting, meaning you should be on a stable regimen. However, if you are taking certain CVD medications like beta-blockers or high-intensity statins, you may not be eligible to participate.
What prior data suggests that Cognitive Processing Therapy is safe for PTSD?
A previous study found that Cognitive Processing Therapy (CPT) was well-tolerated by participants. Reports show that patients, including military personnel and veterans, experienced improvements in PTSD and depression symptoms without major safety concerns. Another study found that people who underwent CPT had lasting positive changes in their PTSD symptoms over time. No major negative effects were reported, suggesting that CPT is safe for treating PTSD.12345
Why are researchers excited about this trial?
Cognitive Processing Therapy (CPT) is unique because it specifically targets the way trauma affects thinking patterns, helping individuals with PTSD reframe and process traumatic events. Unlike other treatments for PTSD, such as medication or exposure therapy, CPT focuses on changing the negative thoughts and beliefs that develop after trauma. Researchers are excited about CPT because it empowers patients to understand and change their thought processes, potentially leading to long-lasting improvements in mental health. This therapy can offer a structured and effective alternative for those who might not respond well to conventional treatments.
What evidence suggests that Cognitive Processing Therapy is effective for PTSD?
Research has shown that Cognitive Processing Therapy (CPT), which participants in this trial may receive, effectively treats PTSD. Studies have found that CPT can significantly reduce PTSD symptoms, with one study noting an average drop of 14 points in symptom severity. CPT has also helped people with PTSD in various groups, including military and veteran communities, by improving both PTSD and depression symptoms. A review of many studies confirmed CPT's long-lasting benefits across various outcomes, proving its effectiveness as a PTSD treatment. Overall, CPT is a dependable therapy for those dealing with PTSD.12367
Are You a Good Fit for This Trial?
This trial is for individuals with PTSD to see if Cognitive Processing Therapy (CPT) can lower their risk of heart disease. Participants should be diagnosed with PTSD but not currently receiving CPT. There's no mention of specific exclusions, so general health requirements likely apply.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete surveys, brain and peripheral imaging, and resting measures of autonomic function
Treatment
Participants receive Cognitive Processing Therapy (CPT) via telehealth
Post-treatment Assessment
Participants attend a post-treatment visit with the same assessments as baseline
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Processing Therapy
Cognitive Processing Therapy is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
American Heart Association
Collaborator